Filing Flows

Filing Flows › Companies › Tenon Medical › Report card

Tenon Medical earnings report card

Every report on file against what analysts and the company itself expected, and what the stock did

Beat rate1 of 4 reports beat the EPS estimate

Tenon Medical (TNON) beat the analysts' EPS estimate in 1 of its last 4 reports (25%), by -4.5% on average. Next report: Nov 12, 2026, analysts expect EPS −$4.22.

Beat rate25% of 4
Average surprise-4.5%
Next reportNov 12, 2026

Report by report

QuarterReportedEPS est.EPS reportedSurpriseGAAP EPSRevenue reported
Q2 2026Aug 13, 2026−$8.40−$12.35-47.0%−$12.35$1.3M
Q1 2026May 12, 2026−$10.68−$10.85-1.6%$0.31$1.4M
Q4 2025Mar 19, 2026−$12.60−$7.70+38.9%—$1.5M
Q3 2025Nov 13, 2025−$12.95−$14.00-8.1%−$0.40$1.2M

Estimates and reported EPS are the Street's adjusted figures; GAAP EPS is from the filing (SEC XBRL). Revenue reported is from the company's filing. No daily prices are on file for these report days, so the stock's moves are not shown.

Charts

Tenon Medical: EPS reported against the estimateTenon Medical: EPS reported against the estimateEstimateReported−$12.95−$14.00Q3 2025−$12.60−$7.70Q4 2025−$10.68−$10.85Q1 2026−$8.40−$12.35Q2 2026
Latest (Q2 2026): Estimate −$8.40, Reported −$12.35.

The next report: what to expect → Tenon Medical: every quarter →

Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.